Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-20

Melda Onal

Federal Grant PI

Assistant Professor

Also affiliated: University of Wisconsin–Madison (2014–2019); Central Arkansas Veterans Healthcare System (2011–2016); Institute for Musculoskeletal Health (2025)

Faculty Researcher

Physiology & Cell Biology, College of Medicine

19 h-index 38 pubs 3,205 cited

  • Animals
  • Mice
  • Osteoblasts
  • Female
  • Autophagy
  • RANK Ligand
  • Osteoclasts
  • Bone Density
  • Male
  • Gene Expression Regulation
  • Mice, Knockout
  • Enhancer Elements, Genetic
  • Bone and Bones
  • Mice, Inbred C57BL
  • Mice, Transgenic

Biography and Research Information

OverviewAI-generated summary

Melda Onal investigates the biological mechanisms underlying bone health and skeletal diseases, with a particular focus on the role of autophagy. Her research utilizes genetically engineered mouse models to explore how specific cellular processes, such as chaperone-mediated autophagy and the regulation of RANK Ligand, impact bone density and strength. Her work has explored the effects of deleting regulatory regions involved in RANK Ligand expression and has examined the utility of CRISPR interference as an alternative to the Cre-loxP system for generating genetically modified animal models.

Dr. Onal has received federal funding from the National Institutes of Health (NIH) for two projects. One grant, totaling $162,184 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, focuses on CRISPR inhibition as an alternative to Cre-loxP. A second grant, for $487,847 from the National Institute on Aging, supports research into the role of autophagy in skeletal diseases. Her scholarship metrics include an h-index of 19 and over 3,191 citations across 38 publications. She actively collaborates with researchers at the University of Arkansas for Medical Sciences, including Jinhu Xiong, Charles A. O’Brien, Maria Almeida, and A. Gordon James, with whom she has co-authored multiple publications.

Metrics

  • h-index: 19
  • Publications: 38
  • Citations: 3,205

Selected Publications

  • TFEB-mediated autophagy stimulation as an anabolic strategy for bone: insights from TFEB activation in the osteoblast lineage (2025)
    Autophagy Reports 1 citation DOI OpenAlex
  • The Aging Landscape by <scp>scRNAseq</scp> of Mesenchymal Lineage Cells in Mouse Bone (2025)
    Aging Cell 5 citations DOI OpenAlex
  • Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength (2025)
    JCI Insight 11 citations DOI OpenAlex
  • Mitochondrial oxidative stress or decreased autophagy in osteoblast lineage cells is not sufficient to mimic the deleterious effects of aging on bone mechanoresponsiveness (2025)
    Aging 4 citations DOI OpenAlex
  • A new <i>Col1a1</i> conditional knock-in mouse model to study osteogenesis imperfecta (2024)
    Journal of Bone and Mineral Research 3 citations DOI OpenAlex
  • CRISPR activation of <i>Tfeb</i> , a master regulator of autophagy and lysosomal biogenesis, in osteoblast lineage cells increases bone mass and strength (2024)
    bioRxiv (Cold Spring Harbor Laboratory) 1 citation DOI OpenAlex
  • Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone (2024)
    Journal of Biological Chemistry 32 citations DOI OpenAlex
  • Loss of chaperone‐mediated autophagy does not alter age‐related bone loss in male mice (2024)
    FASEB BioAdvances 3 citations DOI OpenAlex
  • A framework for defining mesenchymal cell types associated with murine periosteal and endosteal bone (2023)
    bioRxiv (Cold Spring Harbor Laboratory) 1 citation DOI OpenAlex
  • CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system (2023)
    iScience 7 citations DOI OpenAlex
  • Novel methods for the generation of genetically engineered animal models (2022)
    Bone 8 citations DOI OpenAlex
  • Loss of chaperone-mediated autophagy is associated with low vertebral cancellous bone mass (2022)
    Scientific Reports 12 citations DOI OpenAlex
  • Deletion of a putative promoter-proximal Tnfsf11 regulatory region in mice does not alter bone mass or Tnfsf11 expression in vivo (2021)
    PLoS ONE 7 citations DOI OpenAlex
  • Effective CRISPR interference of an endogenous gene via a single transgene in mice (2019)
    Scientific Reports 31 citations DOI OpenAlex
  • A Novel Distal Enhancer Mediates Inflammation‐, PTH‐, and Early Onset Murine Kidney Disease‐Induced Expression of the Mouse <i>Fgf23</i> Gene (2017)
    JBMR Plus 61 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 2 $650,031 total

NIH Contact PI Jun 2026 - Mar 2031

Role of Autophagy in skeletal diseases

National Institute on Aging $487,847 R01
NIH Contact PI Jan 2020 - Dec 2021

CRISPR inhibition as an alternate for Cre-loxP

National Institute of Arthritis and Musculoskeletal and Skin Diseases $162,184 R21

Grants & Funding

As listed on this researcher's institutional profile. Federal awards with verified records are shown above.

  • Center for Musculoskeletal Disease Research (CMDR) NIH/Nat. Inst. of General Medical Sciences Principal Investigator
  • DEAP Awards - P. Drew - UAMS VCRI - FY26 Role of Oligodendrocyte-Lineage Cells in FASD UAMS Division of Research and Innovation Principal Investigator

Collaboration Network

42 Collaborators 4 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics